Le SIDA en Afrique subsaharienne (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.

Identifieur interne : 000C61 ( PubMed/Checkpoint ); précédent : 000C60; suivant : 000C62

The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.

Auteurs : Naadira Vanker [Afrique du Sud] ; Hayley Ipp

Source :

RBID : pubmed:24388088

Descripteurs français

English descriptors

Abstract

A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.

PubMed: 24388088


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24388088

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</title>
<author>
<name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24388088</idno>
<idno type="pmid">24388088</idno>
<idno type="wicri:Area/PubMed/Corpus">001595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001595</idno>
<idno type="wicri:Area/PubMed/Curation">001595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001595</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001595</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001595</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</title>
<author>
<name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</author>
</analytic>
<series>
<title level="j">South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</title>
<idno type="ISSN">0256-9574</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Antigens, CD38 (analysis)</term>
<term>CD4 Lymphocyte Count</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>HIV Infections (immunology)</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Antigènes CD38 (analyse)</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à VIH (immunologie)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Numération des lymphocytes CD4</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antigens, CD38</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Antigènes CD38</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Infections à VIH</term>
<term>Lymphocytes T CD8+</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>CD8-Positive T-Lymphocytes</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>CD4 Lymphocyte Count</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Numération des lymphocytes CD4</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">24388088</PMID>
<DateCreated>
<Year>2014</Year>
<Month>01</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>03</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">0256-9574</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>104</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2013</Year>
<Month>Oct</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</Title>
<ISOAbbreviation>S. Afr. Med. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</ArticleTitle>
<Pagination>
<MedlinePgn>45-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7196/samj.6983</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We hypothesised that FBC parameters would be significantly different in HIV-infected v. -uninfected individuals, and that some of these parameters would correlate with markers of immune activation (i.e. percentage CD38 expression on CD8(+) T cells (%CD38onCD8)) and disease progression (i.e. CD4(+) counts) in HIV infection.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional study with 83 HIV-infected adults who were antiretroviral therapy-naive and clinically well, and 51 HIV-uninfected adults. The %CD38onCD8 and CD4(+) counts were determined by flow cytometry and the FBC was performed on a Siemens ADVIA 2120 system. FBC parameters investigated were total white cell count (WCC), haemoglobin (Hb) concentration, platelet count, absolute neutrophil count, absolute lymphocyte count, and percentage of large unstained cells (%LUCs).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Significant differences were found between the HIV-infected and -uninfected groups for total WCC, Hb, neutrophil count, lymphocyte count and %LUCs. The mean ± standard deviation (SD) for the total WCC (5.3±1.3 v. 6.9±2.2; p≤0.001) and the %LUCs (2.5±0.9 v. 2.0±0.9; p=0.001) both showed correlations with CD4(+) counts and %CD38onCD8.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The total WCC and %LUCs showed significant differences in HIV-infected individuals and correlated with markers of immune activation and disease progression. This suggests the potential use of these parameters as markers of immune activation in HIV infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Vanker</LastName>
<ForeName>Naadira</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ipp</LastName>
<ForeName>Hayley</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>10</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>South Africa</Country>
<MedlineTA>S Afr Med J</MedlineTA>
<NlmUniqueID>0404520</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.2.2.5</RegistryNumber>
<NameOfSubstance UI="D051997">Antigens, CD38</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051997" MajorTopicYN="N">Antigens, CD38</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007958" MajorTopicYN="Y">Leukocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>06</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24388088</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Afrique du Sud</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</noCountry>
<country name="Afrique du Sud">
<noRegion>
<name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C61 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000C61 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24388088
   |texte=   The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24388088" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SidaSubSaharaV1 

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024